GWAS studies reported 40 risk loci associated with AD (Andrews et al., 2020), many of which appear to be associated with immune response/inflammation, APP processing, endocytosis, lipid metabolism, tau pathology, and cell migration (Ikezu and Gendelman, 2016). This evidence concerns the gene MAPT and Alzheimer disease.